Akira Nishimura

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 3

Top Topics

Major Depressive Disorder

Placebo Controlled

Top Venues

Psychiatry and clinical neurosciences

This page only lists publications with an associated author ORCID identifier.

Publications

Takeshi Inoue, Kiyofumi Sasai, Tadayuki Kitagawa, Akira Nishimura, Isao Inada
Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder. Psychiatry and clinical neurosciences 74 (2) (2019)
Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai, Tadayuki Kitagawa, Atul R Mahableshwarkar
Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder. Psychiatry and clinical neurosciences 72 (2) (2017)
Takeshi Inoue, Akira Nishimura, Kiyofumi Sasai, Tadayuki Kitagawa
Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial. Psychiatry and clinical neurosciences 72 (2) (2017)